The effect of NO-COXIBs on genetically modified HIF2α-positive mouse pheochromocytoma (MPC-HIF2α) tumor spheroids was tested to evaluate the application of the compounds with respect to external beam irradiation or radionuclide therapy. The gene discussed is EPAS1; the disease is hereditary pheochromocytoma-paraganglioma.